Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for its Miyapur facility, Hyderabad, Telangana.
The Custom Pharmaceutical Services facility, of Dr Reddy’s Laboratories at the company’s Technology Development Center (TDC-1) in Hyderabad, has received Establishment Inspection Report from the US Food and Drug Administration.
The USFDA has completed the audit of Miyapur facility in September with zero observations.
